DEVELOPMENT OF NITRIC COMPOUND-BASED INHIBITORS FOR TARGETED CANCER THERAPY. FMHR. 2025;3(3):1246-1260. Accessed June 19, 2026. https://fmhr.net/index.php/fmhr/article/view/355